Hyloris Pharmaceuticals SA (EBR:HYL)

Hyloris Pharmaceuticals Revenue

Hyloris Pharmaceuticals had revenue of 4.70M EUR in the half year ending June 30, 2026, with 13.07% growth. This brings the company's total for the last twelve months to 8.89M, up 21.33% year-over-year. In the year 2025, Hyloris Pharmaceuticals had annual revenue of 7.21M, down -14.79%. That makes Hyloris Pharmaceuticals the 36,893rd largest company in the world by revenue and 92nd in Belgium.

• Revenue (ttm): 8.89M
• Revenue Growth: +21.33%
• P/S Ratio: 10.91
• Revenue / Employee: 181.98K
• Employees: 54
• Market Cap: 107.24M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States 4.70M 65.2%
• EMEA and Asia-Pacific 2.51M 34.8%

Fiscal year ended Dec 31, 2025 See the full Hyloris Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.21M	-1.25M	-14.79%
Dec 31, 2024	8.46M	6.37M	305.27%
Dec 31, 2023	2.09M	1.19M	131.89%
Dec 31, 2022	900.00K	-2.20M	-70.93%
Dec 31, 2021	3.10M	2.92M	1,669.14%
Dec 31, 2020	175.00K	84.00K	92.31%
Dec 31, 2019	91.00K	-	-
Dec 31, 2018	91.00K	-122.00K	-57.28%
Dec 31, 2017	213.00K	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Sep 24, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Semi-annually

Last checked:

Oct 30, 2026

Data Sources Report a data error